Importantly, the group suggested that TRIM33 may act as a tumor suppressor in GBM since its downregulation and subsequent Wnt pathway constant activation, promoting tumorigenesis in vivo and GBM cell proliferation in vitro. This evidence concerns the gene TRIM33 and glioblastoma.